LivaNova公共 LIVN 深 沪
等待开盘 12-15 09:30:00 美东时间
62.75
-1.200
-1.88%
华盛通- 最 高64.35
- 今 开64.305
- 成交量 52.29万股
- 最 低 62.64
- 昨 收 63.95
- 总市值 34.21亿
- 52周最高 65.5741
- 市盈率 静 54.16
- 换手率 0.96%
- 52周最低 32.48
- 委 比 0.38%
- 总股本 5452.57万
- 历史最高 131.54
- 量 比 0.83
- 振 幅 2.67%
- 历史最低 23.58
- 每 手 1
- 风险率 6.96%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多LivaNova To Present Eight Posters At AES Highlighting VNS Therapy's Seizure Reduction And Improved Outcomes In Drug-Resistant Epilepsy
Eight scientific posters demonstrate significant seizure reduction and improved outcomes with VNS Therapy in patients with Drug-Resistant EpilepsyLivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company,
12-03 22:03
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
LivaNova Announces 2030 Financial Targets, Sees High-Single-Digit-Plus Revenue CAGR; Adjusted Annual Operating Margin Above 20% Over The Next 3-Years, Targeting High Twenties By 2030; EPS CAGR In The Low Double Digits To Mid-Teens; Adjusted Free Cash Flow Conversion Above 80%
Provides 2030 Targets for Revenue and EPS GrowthLivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today hosted its 2025 Investor Day and presented its comprehensive strategic roadmap and long-range
11-13 04:30
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
LivaNova Raises FY2025 Adj EPS Guidance from $3.70-$3.80 to $3.80-$3.90 vs $3.75 Est, Company Now Expects FY25 Revenue To Grow Between 8.5%-9.5% (Versus 8%-9% Prior)
LivaNova (NASDAQ:LIVN) raises FY2025 Adj EPS guidance from $3.70-$3.80 to $3.80-$3.90 vs $3.75 analyst estimate..
11-05 19:03
LivaNova Q3 Adj. EPS $1.11 Beats $0.92 Estimate, Sales $357.800M Beat $343.505M Estimate
LivaNova (NASDAQ:LIVN) reported quarterly earnings of $1.11 per share which beat the analyst consensus estimate of $0.92 by 20.78 percent. This is a 23.33 percent increase over earnings of $0.90 per share from the same
11-05 19:00
Inspire Medical cut at Jefferies on GLP-1 uptake, potential rivalry
Shares of Inspire Medical Systems (NYSE:INSP) slipped on Friday after Jefferies downgraded the MedTech player to Hold from Buy, citing multiple headwinds for the company, including potential competiti...
10-25 00:39
Doximity, LivaNova downgraded as Goldman Sachs reviews MedTech and Health IT coverage
Doximity (NYSE:DOCS), a digital platform for medical professionals, and LivaNova (NASDAQ:LIVN), a medical equipment maker, traded lower on Wednesday after Goldman Sachs downgraded the duo as part of a...
10-02 01:57
Needham Reiterates Buy on LivaNova, Maintains $64 Price Target
Needham analyst Mike Matson reiterates LivaNova (NASDAQ:LIVN) with a Buy and maintains $64 price target.
09-03 19:58
Barclays Maintains Equal-Weight on LivaNova, Raises Price Target to $58
Barclays analyst Matt Miksic maintains LivaNova (NASDAQ:LIVN) with a Equal-Weight and raises the price target from $55 to $58.
08-21 22:45
